Cargando…
Selective Sensing of Darolutamide and Thalidomide in Pharmaceutical Preparations and in Spiked Biofluids
Selective spectrofluorometric sensing is introduced for the analysis of non-steroidal anti-androgens, darolutamide, and thalidomide in pharmaceutical preparations and biofluids. An organic fluorophore, 2,4,8,10-tetramethylpyrido[2′,3′:3,4]pyrazolo[1,5-a]pyrimidine 2 was synthesized in our laboratori...
Autores principales: | Talaat, Wael, Farahat, Abdelbasset A., Keshk, Reda Mohammed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688659/ https://www.ncbi.nlm.nih.gov/pubmed/36421121 http://dx.doi.org/10.3390/bios12111005 |
Ejemplares similares
-
Darolutamide for prostate cancer
Publicado: (2020) -
PHARMACEUTICALS: New Insights into Thalidomide
por: Brown, Valerie J.
Publicado: (2009) -
Darolutamide For Castration-Resistant Prostate Cancer
por: Bastos, Diogo A, et al.
Publicado: (2019) -
The penumbra of thalidomide, the litigation culture and the licensing of pharmaceuticals
por: Lachmann, P.J.
Publicado: (2012) -
Transdermal Polymeric Microneedle Sensing Platform for Fentanyl Detection in Biofluid
por: Joshi, Pratik, et al.
Publicado: (2022)